SINI THOMAS: Open Payments
NPI 1740729847 · GALVESTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 14 payments from 11 companies in 2025. Trend: 2023 $1,386 · 2024 $1,303 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $333 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Abbott Laboratories | 1 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Corcept Therapeutics | 1 | $113 |
| ABBVIE INC. | 1 | $111 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| ABIOMED | 1 | $82 |
| JAZZ PHARMACEUTICALS INC. | 1 | $78 |
| PFIZER INC. | 1 | $31 |
Products named: REZDIFFRA, PROCLAIM, Livdelzi, SAPHNELO, Korlym, VRAYLAR, Auvelity, Epclusa.
Industry payments across TX — which companies pay providers there.
